Literature DB >> 31753594

NRG3 contributes to cognitive deficits in chronic patients with schizophrenia.

Zezhi Li1, Lihua Liu2, Wei Lin2, Yongjie Zhou3, Guangya Zhang4, Xiangdong Du4, Yi Li3, Wei Tang5, Xiangyang Zhang6.   

Abstract

BACKGROUND: Cognitive deficit is a fundamental trait of schizophrenia, but its mecwhanisms remain unknown. The neuregulin 3 (NRG3) gene, involving in neuronal function, has been considered to be associated with schizophrenia and cognition. However, no study has investigated the effects of NRG3 polymorphism on cognitive deficits in a large sample of the patients with schizophrenia.
METHODS: A total of 1112 schizophrenia patients and 423 controls were recruited and genotyped with NRG3 rs10748842. Among them, 864 patients and 403 controls were assessed for cognition through the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). SHEsis was applied and followed by logistic regression analysis. The models of analyses of covariance (ANCOVA) were constructed to examine the effects of NRG3 rs10748842 on cognitive deficits.
RESULTS: No differences in NRG3 rs10748842 allele and genotype were found between patients and controls (both p > 0.05). With the exception of Visuospatial/construction, the other RBANS scores were significantly lower in patients compared to controls after adjusting for gender and education (all p < 0.001). Interestingly, we found that NRG3 rs10748842 was associated with cognitive deficit in schizophrenia, showing that patients carrying C allele had lower attention and total scores than those with TT genotype (both p < 0.05).
CONCLUSION: NRG3 rs10748842 may not confer susceptibility to schizophrenia, but may be more closely associated with cognitive deficit, especially attention performance in chronic schizophrenia.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognition; NRG3; Polymorphism; Schizophrenia

Mesh:

Substances:

Year:  2019        PMID: 31753594     DOI: 10.1016/j.schres.2019.10.060

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  8 in total

1.  Transcytosis and trans-synaptic retention by postsynaptic ErbB4 underlie axonal accumulation of NRG3.

Authors:  Tanveer Ahmad; Detlef Vullhorst; Rituparna Chaudhuri; Carlos M Guardia; Nisha Chaudhary; Irina Karavanova; Juan S Bonifacino; Andres Buonanno
Journal:  J Cell Biol       Date:  2022-05-17       Impact factor: 8.077

2.  Differences of resting fMRI and cognitive function between drug-naïve bipolar disorder and schizophrenia.

Authors:  Jiaquan Liang; Wei Huang; Huagui Guo; Weibin Wu; Xiaoling Li; Caixia Xu; Guojun Xie; Wensheng Chen
Journal:  BMC Psychiatry       Date:  2022-10-21       Impact factor: 4.144

3.  Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis.

Authors:  Madhu Pujar; Basavaraj Vastrad; Satish Kavatagimath; Chanabasayya Vastrad; Shivakumar Kotturshetti
Journal:  Sci Rep       Date:  2022-06-01       Impact factor: 4.996

4.  Population Genomic Sequencing Delineates Global Landscape of Copy Number Variations that Drive Domestication and Breed Formation of in Chicken.

Authors:  Xia Chen; Xue Bai; Huagui Liu; Binbin Zhao; Zhixun Yan; Yali Hou; Qin Chu
Journal:  Front Genet       Date:  2022-03-22       Impact factor: 4.599

5.  Sexual dimorphism in the relationship between Forkhead-Box P2 and BMI with cognitive deficits in schizophrenia.

Authors:  Mi Yang; Ying Cui; Mei Xue; Mattew T Forster; Xiaoe Lang; Meihong Xiu; Zezhi Li; Xiangyang Zhang
Journal:  Front Aging Neurosci       Date:  2022-08-03       Impact factor: 5.702

6.  Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial.

Authors:  Ming-Huan Zhu; Zhen-Jing Liu; Qiong-Yue Hu; Jia-Yu Yang; Ying Jin; Na Zhu; Ying Huang; Dian-Hong Shi; Min-Jia Liu; Hong-Yang Tan; Lei Zhao; Qin-Yu Lv; Zheng-Hui Yi; Feng-Chun Wu; Ze-Zhi Li
Journal:  Mil Med Res       Date:  2022-10-18

7.  Rare Pathogenic Variants in Genes Implicated in Glutamatergic Neurotransmission Pathway Segregate with Schizophrenia in Pakistani Families.

Authors:  Ambrin Fatima; Uzma Abdullah; Muhammad Farooq; Yuan Mang; Mana M Mehrjouy; Maria Asif; Zafar Ali; Niels Tommerup; Shahid M Baig
Journal:  Genes (Basel)       Date:  2021-11-26       Impact factor: 4.096

8.  Smoking Affects the Patterns of Metabolic Disorders and Metabolic Syndrome in Patients With First-Episode Drug-Naive Schizophrenia: A Large Sample Study Based on the Chinese Han Population.

Authors:  Zezhi Li; Shuning Wang; Yuping Chen; Xi Wu; Yinjun Gu; Xiaoe Lang; Fengchun Wu; Xiang Yang Zhang
Journal:  Int J Neuropsychopharmacol       Date:  2021-10-23       Impact factor: 5.176

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.